EGFR and non-small cell lung carcinoma: Our results showed that the overlapping genes were involved in the KEGG’s cancer-related signaling transduction pathways (hsa05215: prostate cancer, p = 2.2 × 10−3; hsa05223: non-small cell lung cancer, p = 0.024; and hsa04012: ErbB signaling pathway, p = 0.029).